SYDNEY, Australia and MINNEAPOLIS, May 09, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company)(ASX:MEB) (OTCQB:MDBIF), a mental health technology company, is pleased to confirm the next tranche of corporate clients to join the Company’s Corporate Mental Health Check-in.
Medibio welcomes Rio Tinto, AJJV (Aurecon Jacobs Joint Venture for the West Gate Tunnel project), and the Australian Football League to their 4-week Mental Health Check-in campaign.
The ability to measure mental health objectively, and access deep analytics on workforce mental health was a key driver in Rio Tinto - Growth and Innovations division choosing Medibio Corporate Health. This pilot, for 400 people in Iron Ore Projects, will serve as a test case for the larger organization.
“After hearing about the Mental Health Check-in from a business partner, Rio Tinto approached Medibio Corporate Health. They have been thorough in understanding the program’s technology, applicability and analytics, and we look forward to working with them,” SVP Corporate Health, Peta Slocombe.
The West Gate Tunnel Project is the largest infrastructure project in the Southern Hemisphere. The project is committed to increasing worker health and safety over the life of the project. The Check-in will be available to workers on and offsite, and seeks to understand the analytics behind mental health, safety and high performance.
Australian Football League (AFL) and Australian Football League Umpires Association (AFLUA), are collaborating to provide a Mental Health Check-in for all Umpires and Football Operations Staff. Elite athletes require an agile, responsive and alert mind, the Check-in delivers umpires with their personal dashboard for psychological high performance, and their employer with de-identified data and strategies for better umpire mental health.
Medibio CEO Jack Cosentino noted, “These partnerships with some of the biggest names in these sectors, position them as leaders in mental health care technology.”
The Mental Health Check-in campaign is the entry level offering to Medibio’s annualized Corporate Health product. Collectively, they will contribute up to 1,400 participants to Medibio’s data set, and paid pilots with two global mining and construction firms.
About Medibio Limited
Medibio (ASX:MEB) (OTCQB:MDBIF) is a mental health technology company that has pioneered the use of objective biometrics to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions. The company was founded in Australia, with offices now located in Melbourne (Vic), Perth (WA) and Minneapolis, MN. Medibio is listed on the Australian Securities Exchange Ltd and trades on the OTCQB Venture Market. Investors can find additional information on www.otcmarkets.com and www.asx.com.au.
| Further Information: | Website: www.medibio.com.au | |
| Medibio Shareholder Enquiries: Stephanie Ottens Investor Relations Director Medibio Limited stephanie.ottens@medibio.com.au T: +61 434 405 400 | Australian Media Enquiries: Peter Taylor NWR Communications peter@nwrcommunications.com.au T: +61 (0) 412 036 231 | |